Vicore Pharma Holding AB Sponsored ADR(VCRE)
$9.90-0.22 (-2.17%)
VCRE
Vicore Pharma Holding AB Sponsored ADR financials statements
$9.90
At close:-0.22 (-2.17%)
Vicore Pharma Holding AB Sponsored ADR (VCRE) Financial Statements
3 Followers
Vicore Pharma Holding AB Sponsored ADR Financial Overview
Vicore Pharma Holding AB Sponsored ADR's market cap is currently kr284.42M. The company's EPS TTM is kr-5.92; its P/E ratio is -5.47; Vicore Pharma Holding AB Sponsored ADR is estimated to report earnings on February 25, 2027, and the estimated EPS forecast is kr-0.53. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | |
|---|---|
| Income Statement | |
| Total Revenue | kr 3.82M |
| Gross Profit | kr 3.82M |
| Operating Income | kr -454.44M |
| EBITDA | kr -477.41M |
| Net Income | kr -477.47M |
| Balance Sheet | |
| Cash & Short-Term Investments | kr 1.17B |
| Total Assets | kr 1.22B |
| Total Debt | kr 0.00 |
| Net Debt | kr -578.15M |
| Total Liabilities | kr 123.17M |
| Stockholders' Equity | kr 1.10B |
| Cash Flow | |
| Free Cash Flow | kr -375.74M |
| Operating Cash Flow | kr -375.74M |
| Investing Cash Flow | kr -600.51M |
| Financing Cash Flow | kr 430.54M |
Currency in SEK

